Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Migraine, With or Without Aura”

66 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 66 results

Large-scale testing (Phase 3)Looking for participantsNCT04743141
What this trial is testing

Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine

Who this might be right for
Acute Treatment of Migraine
Pfizer 600
Post-approval studies (Phase 4)Study completedNCT00753311
What this trial is testing

Rizatriptan in Acute Treatment of Migraine in Patients With Unilateral Trigeminal-autonomic Symptoms.

Who this might be right for
Migraine
IRCCS San Raffaele 80
Large-scale testing (Phase 3)Study completedNCT00122278
What this trial is testing

Headache in the Emergency Department (ED) - A Multi-Center Research Network to Optimize the ED Treatment of Migraines

Who this might be right for
Migraine
Montefiore Medical Center 205
Large-scale testing (Phase 3)Study completedNCT00382993
What this trial is testing

Combination Product (Sumatriptan Succinate and Naproxen Sodium) in Migraine Subjects Who Report Poor Response or Intolerance to Short Acting Triptans (Study 2 of 2)

Who this might be right for
Migraine Disorders
GlaxoSmithKline 169
Large-scale testing (Phase 3)Study completedNCT01989936
What this trial is testing

Eletriptan for the Treatment of Migraine in Patients With Previous Poor Response or Tolerance to Oral Sumatriptan

Who this might be right for
Migraine With or Without Aura
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 446
Large-scale testing (Phase 3)Study completedNCT03009019
What this trial is testing

Efficacy, Tolerability, and Safety of DFN-15

Who this might be right for
Migraine Headache
BioDelivery Sciences International 631
Testing effectiveness (Phase 2)Study completedNCT06728553
What this trial is testing

Safety and Efficacy Trial of MTX101 2mg for the Acute Treatment of Migraine in Adults

Who this might be right for
Migraine
Manistee Therapeutics 78
Large-scale testing (Phase 3)Study completedNCT02605174
What this trial is testing

Three Doses of Lasmiditan (50 mg, 100 mg and 200 mg) Compared to Placebo in the Acute Treatment of Migraine

Who this might be right for
Migraine With or Without Aura
Eli Lilly and Company 3,005
Not applicableActive Not RecruitingNCT07292506
What this trial is testing

The Impact of Acupuncture on Biomarkers of Brain Injury and Inflammatory Response in Migraine

Who this might be right for
MigraineMigraine HeadacheMigraine Headache, With or Without Aura+1 more
University Medical Centre Ljubljana 75
Post-approval studies (Phase 4)Study completedNCT00792636
What this trial is testing

Determine the Effect of Sumatriptan and Naproxen Sodium Combination Tablet, Sumatriptan Tablet, and Naproxen Sodium Tablet on Blood Pressure When Treating Migraine Headaches That Occur During a 6-month Period

Who this might be right for
Migraine Disorders
GlaxoSmithKline 407
Not applicableUnknownNCT05517200
What this trial is testing

Pilot Study for a Machine Learning Test for Migraine

Who this might be right for
MigraineChronic MigraineTension-Type Headache
Headache Sciences Incorporated 20
Large-scale testing (Phase 3)Study completedNCT01978496
What this trial is testing

Efficacy, Safety, and Tolerability of Oral Eletriptan for Treatment of Acute Migraine

Who this might be right for
Migraine With or Without Aura
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 1,334
Not applicableLooking for participantsNCT06203873
What this trial is testing

A Comparison of Biodegradable and Metal Occluders in Patients With PFO and Migraine

Who this might be right for
PFO - Patent Foramen OvaleMigraineMigraine Headache+1 more
Chinese Academy of Medical Sciences, Fuwai Hospital 400
Testing effectiveness (Phase 2)Study completedNCT00422812
What this trial is testing

Staccato Prochlorperazine in Migraine (Out Patient)

Who this might be right for
Migraine HeadacheAura
Alexza Pharmaceuticals, Inc. 400
Large-scale testing (Phase 3)Ended earlyNCT03338920
What this trial is testing

Study to Assess the Safety and Efficacy of ONZETRA® Xsail® for the Acute Treatment of Episodic Migraine With or Without Aura in Adolescents

Who this might be right for
Acute Migraine With or Without Aura
Currax Pharmaceuticals 159
Not applicableLooking for participantsNCT07292090
What this trial is testing

Yogabased Movements for Primary Headaches (Migraine and/or Cluster Headache) - YOURHEAD - a Pilot Study

Who this might be right for
Cluster Headache - Episodic and ChronicMigraine HeadacheMigraine Headache, With or Without Aura+4 more
Karolinska Institutet 40
Large-scale testing (Phase 3)Study completedNCT00387881
What this trial is testing

TREXIMET (Formerly Known as TREXIMA) for the Acute Treatment of Probable Migraine (ICHD-II 1.6.1)

Who this might be right for
Migraine, Without Aura
GlaxoSmithKline 679
Testing effectiveness (Phase 2)Study completedNCT00610428
What this trial is testing

Staccato Prochlorperazine in Migraine (in Clinic)

Who this might be right for
Migraine Headache, With or Without Aura
Alexza Pharmaceuticals, Inc. 75
Post-approval studies (Phase 4)Looking for participantsNCT07022496
What this trial is testing

Assessment of Oral Caffeine Intake in Changing the Severity of Acute Migraine Attack Using VAS Score Among Patients Attending Headache and Neurology Outpatients Clinic of Ainshams University Hospitals

Who this might be right for
MigraineMigraine DiseaseMigraine Headache+2 more
Ain Shams University 120
Large-scale testing (Phase 3)Study completedNCT02848326
What this trial is testing

Efficacy, Safety, and Tolerability of Multiple Dosing Regimens of Oral Atogepant (AGN-241689) in Episodic Migraine Prevention

Who this might be right for
Migraine, With or Without Aura
Allergan 834
Load More Results